Is monotherapy for febrile neutropenia still a viable alternative?

Clicks: 334
ID: 111391
1999
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Monotherapy for empirical treatment of febrile neutropenia is effective and often less costly than combination therapy but remains controversial. The controversy results from observations that combination therapy for Pseudomonas aeruginosa improved outcomes, and this approach became a standard. Many ā€¦
Reference Key
r1999clinicalis Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ramphal R;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 1999
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10530437
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review clinical trials as topic humans pubmed abstract nih national institutes of health national library of medicine prognosis Comparative Study drug resistance bacterial infections / microbiology microbial anti-bacterial agents / administration & dosage* drug therapy pmid:10530437 doi:10.1086/598623 r ramphal bacterial infections / complications bacterial infections / drug therapy* combination / therapeutic use fever / diagnosis fever / etiology fever / prevention & control* neutropenia / diagnosis neutropenia / etiology neutropenia / prevention & control*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.